Innovative Antibodies Laboratory (InnoAbs) is a global leading research group in the field of antibody engineering and therapeutic antibody development. InnoAbs Lab's research has focused on investigating the roles of antibody-based targeting of a variety of novel potential therapeutic targets, especially those related to immunological disorders, infectious diseases, and the progression and metastasis of cancer in collaboration with a wide range of academic and industrial partners.